This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Genetic Engineering Remove Hormones Related Topics
Genotoxicity Bioassay In-Vivo Gene Expression RNA In-Vitro Bacteria Genetics Gene Regulation More Related Topics >
article thumbnail

Gene Switch: A Novel Platform for Switching Genes On and Off

Roots Analysis

AUGUST 31, 2023

For instance, studies have demonstrated that gene switches incorporated in gene therapies being developed for the treatment of anemia can regulate the production of hormone erythropoietin. Additionally, the genetically modified cell therapies might transform into uncontrollable mutant cells when the switch is inactivated.

Gene 40
Gene Gene Therapy Gene Expression Regulation 40
article thumbnail

Accelerating NDA filing through faster carcinogenicity assessment

Drug Discovery World

MAY 10, 2023

They encourage an integrated analysis of risk considering many factors, including drug target biology and evidence for hormonal or immunological perturbation. Moving forward The latest revisions to ICH S1B represent a significant modernisation of carcinogenicity assessment of small molecule drugs. Toxicologic Pathology. 2011;39(4):716-744.

Bioassay 52
Bioassay Genotoxicity Drugs In-Vivo 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024